arrow
K

Klaas Kok

University of Groningen
H指数:44
被引数:8,859

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A comprehensive overview of the heterogeneity of EGFR exon 20 variants in NSCLC and (pre)clinical activity to currently available treatments

非小细胞肺癌中EGFR外显子20变异的异质性和目前可用治疗的 (前) 临床活性的综合概述

2023-11-018
OA
Genomic profiling of post-transplant lymphoproliferative disorders using cell-free DNA
2023-09-144
OAAI
circPVT1 and PVT1/AKT3 show a role in cell proliferation, apoptosis, and tumor subtype-definition in small cell lung cancer

circPVT1和PVT1/AKT3在小细胞肺癌的细胞增殖,凋亡和肿瘤亚型定义中发挥作用

2023-01-2312
OA
CD4+T cells in classical Hodgkin lymphoma express exhaustion associated transcription factors TOX and TOX2 Characterizing CD4+T cells in Hodgkin lymphoma

经典霍奇金淋巴瘤中的CD4 T细胞表达耗竭相关转录因子TOX和TOX2,表征霍奇金淋巴瘤中的CD4 T细胞

2022-01-2720
OA
Clinical Value of EGFR Copy Number Gain Determined by Amplicon-Based Targeted Next Generation Sequencing in Patients with EGFR-Mutated NSCLC

基于扩增子的靶向下一代测序确定EGFR拷贝数增加在EGFR突变的NSCLC患者中的临床价值

2021-02-199
OAAI
Clinical value of EGFR gene amplifications detected using amplicon based targeted next generation sequencing data in lung adenocarcinoma patients

基于扩增子的靶向下一代测序数据检测肺腺癌患者EGFR基因扩增的临床价值

2020-08-150
PRE
Cellular senescence impairs the reversibility of pulmonary arterial hypertension
2020-07-2974
OAAI